chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Patient came to receive her covid vaccine at 11:00. This was her first dose in the series. She received the Pfizer vaccine. She has no known allergies. I gave paitent her injection at 11:10. I told her to wait 15 minutes in the waiting room in case of an adverse reaction. At 11:20 she reported feeling cold and dizzy. I brought her back to our injection room and had her sit down. She was pale, sweating, and moving very slow. She reported feeling very dizzy, nauseous, and reported having stomach cramps. When she sat down she said she was hot, so I helped her remove her jacket. I checked her vitals at 11:25 - HR was 107, BP 116/75, O2 saturation 100%. I continued to sit with her and her symptoms persisted. Her vitals at 11:33  - BP 112/75, HR 87, 02 100% on room air.  At 11:40 she said the dizziness was easing off, but the cramping was remaining. She was not sweating anymore but was still a little pale. Her vitals were BP 109/98, HR 99, O2 99%.  At 12:00 I had NP-C come assess and talk to patient. Patient was still cramping and felt dizzy when she stood and her heart rate did increase to 110 when she stood, but it came back down to the 80s within a short time. Patient reported feeling her heart rate increase in her chest, but did not feel faint. She sat back down and I checked her vitals again. HR 80 and O2 100%. At 12:30 she stood again and did not feel dizzy. Her skin tone was back to normal and not pale. We stood together for a little while to assess how she was feeling.  NP-C said that she approved for her to go home now, and instructed her not to go back to work, but to go home and rest. NP-C told patient that if she had chest pain or tightness later to go to the emergency room. I walked with  down the stairs, out the door, and to her car. She left at 12:40. Patient text me at 1:08 and let me know that she had made it home.
stiff neck; swollen lymph nodes; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP).  A male patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) for 1 day as dose number unknown , single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: MUSCULOSKELETAL STIFFNESS (non-serious), outcome "unknown", described as "stiff neck"; LYMPHADENOPATHY (non-serious), outcome "unknown", described as "swollen lymph nodes".  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021301279 Same reporter/drug/event, different patient.
falling down; Left leg lost movement and feeling and then both legs; Left leg lost movement and feeling and then both legs; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 78-year-old male patient received BNT162b2 (BNT162B2), in Feb2021 as dose 1, single (Batch/Lot number: unknown), in left arm for covid-19 immunisation. The patient's relevant medical history included: "Abalone" (unspecified if ongoing). There were no concomitant medications. Past drug history included: Sulpa drug, reaction(s): "Allergy: sulpa drug". The following information was reported: SENSORY LOSS (disability, medically significant), MOBILITY DECREASED (disability, medically significant) all with onset 2021, outcome "not recovered" and all described as "Left leg lost movement and feeling and then both legs"; FALL (disability, medically significant) with onset 2021, outcome "not recovered", described as "falling down". Therapeutic measures were taken as a result of fall, sensory loss, mobility decreased. Clinical course: Patient started falling down 5 or so days after the vaccine. Left leg lost movement and feeling and then both legs after 3 or so months. Patient had undergone back surgery then IVIG 27 doses so far. It was reported that the onset date and time of the events are 25Jan2021 14:00 (discrepant information). Patient was vaccinated at 04:00   The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202300258727 same reporter/patient/product/event, different dose;
red rash; red rash /  rash comes and goes; itching and burning in his left arm; burning in his left arm /  rash comes and goes and gets red and then light; rash comes and goes and gets red and then light; This case was reported by a consumer via call center representative and described the occurrence of rash in a 61-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   On 26th February 2021, the patient received the 1st dose of Shingrix. On 26th February 2021, less than a day after receiving Shingrix, the patient experienced rash, erythema, pruritus, burning sensation and decoloration skin. On an unknown date, the outcome of the rash, erythema, pruritus, burning sensation and decoloration skin were unknown.   It was unknown if the reporter considered the rash, erythema, pruritus, burning sensation and decoloration skin to be related to Shingrix.  Additional details were provided as follows: The patient reporter case for himself. Right after receiving the Shingrix dose, patient experienced itching and burning in his left arm and a red rash right under where he received the vaccination. He claimed that the rash came and went and gets red and then light. He had burning and itching too. The reporter consented to follow up.
noticed has swelling underneath the armpit on the side of the injection site and it's hurting; noticed has swelling underneath the armpit on the side of the injection site and it's hurting; This is a spontaneous report from a contactable consumer (patient) via Medical information team. A female patient of an unspecified age received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot Number: Unknown), via an unspecified route of administration on an unspecified date as single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. On an unspecified date, the patient noticed swelling underneath the armpit on the side of the injection site and it's hurting. The patient did not have anything after 1st dose. The patient asked whether she could take anything or should go to the ER. The outcome of the event was unknown.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
I am not sure which type of flu vaccine I received. It was given at my place of work. I broke out in hives on my chest, neck, legs, arms, hands, back, feet, head. Hives are of different sizes scattered over the body and itchy. It keeps coming back even after steroid injections and antiallergic medication.
One week after injection arm became very  red and itchy at the injection site ,lasting for over a week
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 72-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 19Feb2021 at 11:00 as dose 1, single (Lot number: EN6201), in left arm, on 12Mar2021 at 16:30 as dose 2, single (Lot number: EN6207), in left arm, on 04Oct2021 at 16:45 as dose 3 (booster), single (Lot number: FC3184), in left arm and on 31Mar2022 at 10:00 as dose 4 (booster), single (Lot number: FM0698) at the age of 71 years, in left arm for covid-19 immunisation. The patient's relevant medical history included: "sulfa drugs - minor allergy" (unspecified if ongoing). There were no concomitant medications. The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant) all with onset 06Jun2022, outcome "not recovered" and all described as "COVID 19 Treatment". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (unspecified date) Positive, notes: Treatment of COVID-19; (13Jun2022) Positive. Therapeutic measures were taken as a result of vaccination failure, covid-19. Clinical information: No other medication in 2 weeks. She was concerned that after ending the 5 day course of Paxlovid which started on 08Jun2022 and stopped on 12Jun2022 at 8:00PM, she was still tested positive for COVID 19 on 13Jun2022. The symptoms was very mild, just a drippy nose.  No follow-up attempts are possible. No further information is expected.
On the 8th days (3/14) after the 1st dose of Moderna COVID-19 vaccine, a huge lump (3 inches in diameter) developed on the injection site. It is red, itching, hard, and with a warm sensation. The next day, it got even bigger, extended downward and inward on the arm, but it is not as hard.  It is still red, itching, and warm.  I will continue monitoring it and report as I see changes.
Headache 2 days post yellow fever vaccine (3/8/08) until 4/3/08 after he had a fever overnight.  They were out of town at the time without a thermometer to measure his fever. (Wife has the same headache).
Rt arm sore, red, hot for two days since Td, arm with HEB OK. Rt has a erythematous, warm area 5x3. Ampicillin  and Benadryl.
Received 2nd dose 03/31/2021. On 12/22/2021- tested positive for COVID-19, fever, fatigue, I was extremely exhausted. Taking a shower took all of my energy. I had shortness of breath. Coughing was the last one to go away. I had body aches and muscle aches. After receiving the 3rd dose of Moderna, I started having symptoms on 02/05/2022. I woke up with a ball in my armpit. Around 10 pm, on 02/05/2022, I notice I had shortness of breath. It woke me up. I felt winded after walking. Just recently, I started noticing I had shortness of breath and I started checking my pulse. My pulse oximeter does not get any higher then 98. Before It was reading like 100. Now it reads 96, 97, and does not go higher than 98. My doctor said that as long as it is not affecting my daily activities, that I should just monitor it. I have recovered from everything, except my shortness of breath.
Patient experienced fever (T-max unknown) and chills. Symptoms resolved after 48 hours. Patient did not require medical treatment. Patient took 2 sick days off of work as a result of the symptoms.
Mom describes onset of fever 9APR91 highest temp 104; 13APR91 child covered w/rash fr head to toe; Described as blotchy, smooth to touch, involving face torso & all 4 extremities; fever dec @ this time lymph nodes swollen 24APR91;
came to the clinic tonight and was inadvertently given a 22 mcg dose of vaccine. I spoke to mom while they were at the clinic, and she did not exhibit any unusual symptoms during the 15 min observation period. I explained what happened and that she should be watched closely over the next several days. If she exhibits any unusual symptoms, she was counseled to see her family doctor, urgent care, or the ED.  Later that night I also received request at 1712 from father for a call back. I spoke to him and answered all his questions.  Father sent me a text message the next day (11/19) to report she was doing well. I answered his text and all questions.
Red, inflamed, tender, warm to touch slight swelling 7/10; by 7/11/and 7/12 the swelling involved upper and lower arm.
Information regarding Prevenar (pneumococcal 7-valent conjugate vaccine (diphtheria crm197 protein) injection) was received from a healthcare professional regarding a 4 year old female patient who experienced injection site swelling, injection site redness and injection site bruising. The patient received a dose in Sept 2005. Relevant medical history was not provided. Indication for Prevenar was immunisation. Product was administered in Sept 2005. Dose regimen was 1 dose 1 time per day intramuscular. Additional suspect medication included DTP vaccine (diphtheria and tetanus toxoids and pertussis). Concomitant medications were not reported. The patient experienced injection site swelling, injection site redness, and injection site bruising (injection site Hemorrhage) in Sep 2005, No additional information was available at the time of this report.
There was no adverse event.  Patient initial vaccine dose was Pfizer.  She was unable to get her second Pfizer shot due to hospitalization.  She unknowingly signed up for a Moderna vaccine.   When she arrived for her 2nd vaccine, we realized it was not the same series. We opted to give her a second dose of Moderna vaccine as she was car bound and we had the resources to walk the vaccine out to her car and watch her for an adverse reaction while still in the car.  We tried but were unable to locate a facility that could give her her Pfizer vaccine while cart bound.  The patient was not sure she would bother to get a 2nd dose if we did not give it to her that day.  We discussed  and thought 3 doses of different vaccines was better than one incomplete series
HIGH BLOOD PRESSURE; COULDN'T WALK; COULDN'T DO ANYTHING; SO SICK; NOT FEELING WELL; VERTIGO; VOMITING; NAUSEA; This spontaneous report received from a patient concerned a 96 year old female. The patient's weight was 128 pounds, and height was not reported. The patient's concurrent conditions included arthritis, neuropathy, thyroid issue, non smoker, non alcohol user, diabetes, and cannot walk without a walker, and other pre-existing medical conditions included patient had no known allergies. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1805022 expiry: 25-MAY-2021) dose was not reported, administered on 30-MAR-2021 for prophylactic vaccination. No concomitant medications were reported. On MAR-2021, the subject experienced vomiting. On MAR-2021, the subject experienced nausea. On 31-MAR-2021, the subject experienced vertigo. On an unspecified date, the subject experienced high blood pressure, couldn't walk, couldn't do anything, so sick, and not feeling well. Laboratory data (dates unspecified) included: Blood pressure (NR: not provided) 200 over something. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from vertigo, high blood pressure, not feeling well, couldn't walk, couldn't do anything, and so sick, and the outcome of nausea and vomiting was not reported. This report was non-serious.
This case was reported by a consumer via call center representative and described the occurrence of dizziness in a 69-year-old male patient who received SHINGRIX for prophylaxis. On 21st September 2018, the patient received the 2nd dose of SHINGRIX .5 ml. In September 2018, less than a week after receiving SHINGRIX the patient experienced dizziness, nausea, pain in arm and fever. The patient was treated with acetylsalicylic acid (Aspirin). On an unknown date, the outcome of the dizziness, nausea and fever were recovered/resolved and the outcome of the pain in arm was not recovered/not resolved. It was unknown if the reporter considered the dizziness, nausea, pain in arm and fever to be related to SHINGRIX. Additional details were provided as follows: This case was reported by the patient for himself. The patient received SHINGRIX in the left arm. After receiving SHINGRIX, he experienced dizziness, in particular when bending over to pick something up off of the floor, fever and mild nausea without vomiting. He took Aspirin and the fever resolved. The dizziness and nausea resolved within that day. The patient had a sore arm that had not resolvedat the time of reporting.
Patient came for her second dose and told us when she got her first dose on 3/11/21  Lot number EN6206 she has severe muscle cramps that day. It was so bad it turned black and blue.  We asked if her doctor was okay with her second dose she said yes.
Information has been received from an office manager concerning an 87 year old female consumer with degenerative joint disease, hypertension and drug allergies to ACTONEL, alendroanate sodium, MIACALCIN and glucosamine who on 07-FEB-2008 was vaccinated with a single series of zoster vaccine live (Oka/Merck) (lot # 659326/1824U). Concomitant therapy included "some different medications." The office manager reported the patient received the vaccination and then three weeks later on approximately 28-FEB-2008 the patient broke out in a mild case of shingles, which were not painful. The patient had red spots that were located on her back and "flack" area. It was noted that the patient did not tell the physician until she came in for her routine check up on 03-APR-2008. There were no lab studies performed. At the time of the report the patient still had some spots on her body, but she was recovering. There was no product quality complaint involved, Additional information has been requested. The patient also had an adverse experience after being placed on therapy with alendroanate sodium (WAES # 0804USA02780).
This spontaneous report as received from a physician refers to a female patient of unknown age. The patient was vaccinated subcutaneously with a dose of ZOSTAVAX (Lot# and dose not reported) on 01-OCT-2012. While on ZOSTAVAX the patient experienced shingles (date not reported). The patient sought for unknown medical attention. The outcome of shingles was unknown. Additional information is not expected.
Feeling that something was wrong, headache, racing heart beat, short of breath, dizziness, weakness, inability to stand, hot then cold, shaking, chills,
Dizziness, Headache, NauseaVomiting, FATIGUE Narrative:
patient was sicker than a dog for up to 6 weeks; Initial information was received on 05-Nov-2020 regarding an unsolicited valid non-serious case received from a consumer (patient) via social media.  This case involves a patient of unknown age and gender who was sicker than a dog for up to 6 weeks (illness), while he/she received vaccine INFLUENZA VACCINE.  The patient's vaccination(s) included Influenza vaccine as prophylactic vaccination The patient's medical history, concomitant therapy, medical treatment(s) and family history were not provided.   On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer (lot number and expiry date not reported) via unknown route in unknown administration site for prophylactic vaccination.  On an unknown date, the patient was sicker than a dog for up to 6 weeks (illness) (Unknown latency) following the administration of INFLUENZA VACCINE.  Details of laboratory data were not reported.   It was not reported if the patient received any corrective treatment.  At the time of reporting, outcome of the event was unknown.  There will be no information available on batch number for this case.
I got Flu and RSV vaccines on 9/28/23. Then the latest Covid vaccine on 10/03/23.  On 10/28/23 I suffered an ischemic stroke to my left frontal lobe.  I did not have a prior history of either high blood pressure or cholesterol.   The effect of my stroke is weakness to my right hand.
It was reported to us that the day after she got her routine vaccination that she had a seizure and went to the emergency room. No fever @ the time of/or after seizure. On 11/18 she had 2 more seizures and was hospitalized for them and is now on medication for the seizures.
Bullous skin disease (clinically consistent with Linear IgA, however DIF negative), began 10 days after vaccination (no new medications or recent illness otherwise). Stabilized with prednisone but has not resolved as of 7/16/2021
Client had Moderna LOT 013A21A  on 3/3 no documentation on person or in registry.  First dose of Pfizer as above on 3/18/2021; and Completed Moderna Series 3/31 Moderna Lot 019B21A
Pt recv vax on 9/11/98; 1 hr later pt exp trembling, fever (105.8), mottled appearance.  Pt sent to E.R.
I had a retinal artery occlusion that resulted in blindness in the lower half of my right eye within 5.5 hours of receiving the vaccine.
vaccines were stored in a standard freezer but temperature 2 degrees F high -1 degrees F low; Vaccine administered to 45 patients past 30-day use by date.; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Vaccine administered to 45 patients past 30-day use by date.) and PRODUCT STORAGE ERROR (vaccines were stored in a standard freezer but temperature 2 degrees F high -1 degrees F low) in an adult patient of an unknown gender who received mRNA-1273 (Spikevax) (batch no. 031B21A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 08-Nov-2021, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 08-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Vaccine administered to 45 patients past 30-day use by date.). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (vaccines were stored in a standard freezer but temperature 2 degrees F high -1 degrees F low). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Vaccine administered to 45 patients past 30-day use by date.) and PRODUCT STORAGE ERROR (vaccines were stored in a standard freezer but temperature 2 degrees F high -1 degrees F low) outcome was unknown.        For mRNA-1273 (Spikevax) (Unknown), the reporter did not provide any causality assessments.   No Concomitant medication was reported.  It was reported that vaccines were stored in a standard freezer. A total of 45 doses from the outlined lot numbers were administered past the expiration date.  All 45 patients were adults, who received the Moderna vaccine beyond the 30-day use by date. No additional information provided.   No treatment medication was reported.
Delayed development, diarrhea, didn't sleep all night until age 2, craved certain foods, twirls cords and spins around, constant hand flapping, temper tantrums, GFCG diet, nystatin for stomach, methyl biz shots, vitamins, chelation.
Pain and swelling occurred within 24 hours, at injection site. Minimal less than 2cm diameter of erythema. No warmth, no lymphadenopathy. Injections site on right deltoid. Pain, swelling and redness is gone.
A 51 year old female patient received 0.5ml of a pneumococcal vaccine during her doctor's visit on 05/02/2005. On 05/03/20005 she experienced chills for approximately 6 hours in the late afternoon. On 05/04/2005 the injection site on her left upper arm was red, hard and slightly swollen.
Upper (L) arm red, swollen, and warm touch. Symptoms began today 8/21/08. Has appt to see PMD today at 345 PM.
Information has been received from a 71 year old male who on 12-DEC-2007 was vaccinated with zoster vaccine live (Oka/Merck), 0.65 mL, subcutaneous injection (lot #6597601/0159X). Concomitant therapy included naproxen, ranitidine, gabapentin, hydrocodone bitartrate, simvastatin (MSD), terazosin hydrochloride, finasteride (manufacturer unknown), duloxetine hydrochloride and alendronate sodium (MSD). On Friday, 16-MAY-2008, the patient experienced a sore throat. "The following Sunday," on 18-MAY-2008, he saw blisters on the back of his tongue when he look in a mirror. He was seen by his health care professional and was told it was a herpes rash. As of 20-MAY-2008, the patient was recovering. The product quality complaint unit was not involved. Additional information has been requested.